Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2i or DPP4i Added to Premix Insulin in Uncontrolled Type 2 Diabetes
NCT03458715Phase 4Unknown
- Sponsor
- Mackay Memorial Hospital
- Start
- Sep 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin, linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Mackay Memorial Hospital. Status: unknown.
02
Drugs
empagliflozinlinagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03458715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03458715.